The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Fungal Otitis Externa Market Research Report 2024
Synopsis
Fungal ear infection is an infection of the ear with a fungus. It normally involves the canal that runs from the ear hole to the eardrum (the external auditory canal).Most cases can be treated with over-the-counter analgesics and topical eardrops.
Global Fungal Otitis Externa market is projected to reach US$ 274.2 million in 2029, increasing from US$ 190 million in 2022, with the CAGR of 5.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Fungal Otitis Externa market research.
Key companies engaged in the Fungal Otitis Externa industry include Novartis, Sanofi, Par Pharmaceutical, Hi Tech Pharmaceuticals, Hill Dermaceuticals, NuLife Pharmaceuticals, Pfizer, Janssen Pharmaceuticals and Mylan N.V., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Fungal Otitis Externa were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Fungal Otitis Externa market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Fungal Otitis Externa market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Novartis
Sanofi
Par Pharmaceutical
Hi Tech Pharmaceuticals
Hill Dermaceuticals
NuLife Pharmaceuticals
Pfizer
Janssen Pharmaceuticals
Mylan N.V.
Salvat Laboratories
Segment by Type
Ear Drops
Oral Medications
Topical Medications
Others
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Fungal Otitis Externa report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Fungal ear infection is an infection of the ear with a fungus. It normally involves the canal that runs from the ear hole to the eardrum (the external auditory canal).Most cases can be treated with over-the-counter analgesics and topical eardrops.
Global Fungal Otitis Externa market is projected to reach US$ 274.2 million in 2029, increasing from US$ 190 million in 2022, with the CAGR of 5.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Fungal Otitis Externa market research.
Key companies engaged in the Fungal Otitis Externa industry include Novartis, Sanofi, Par Pharmaceutical, Hi Tech Pharmaceuticals, Hill Dermaceuticals, NuLife Pharmaceuticals, Pfizer, Janssen Pharmaceuticals and Mylan N.V., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Fungal Otitis Externa were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Fungal Otitis Externa market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Fungal Otitis Externa market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Novartis
Sanofi
Par Pharmaceutical
Hi Tech Pharmaceuticals
Hill Dermaceuticals
NuLife Pharmaceuticals
Pfizer
Janssen Pharmaceuticals
Mylan N.V.
Salvat Laboratories
Segment by Type
Ear Drops
Oral Medications
Topical Medications
Others
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Fungal Otitis Externa report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fungal Otitis Externa Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Ear Drops
1.2.3 Oral Medications
1.2.4 Topical Medications
1.2.5 Others
1.3 Market by Application
1.3.1 Global Fungal Otitis Externa Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fungal Otitis Externa Market Perspective (2018-2029)
2.2 Fungal Otitis Externa Growth Trends by Region
2.2.1 Global Fungal Otitis Externa Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Fungal Otitis Externa Historic Market Size by Region (2018-2023)
2.2.3 Fungal Otitis Externa Forecasted Market Size by Region (2024-2029)
2.3 Fungal Otitis Externa Market Dynamics
2.3.1 Fungal Otitis Externa Industry Trends
2.3.2 Fungal Otitis Externa Market Drivers
2.3.3 Fungal Otitis Externa Market Challenges
2.3.4 Fungal Otitis Externa Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fungal Otitis Externa Players by Revenue
3.1.1 Global Top Fungal Otitis Externa Players by Revenue (2018-2023)
3.1.2 Global Fungal Otitis Externa Revenue Market Share by Players (2018-2023)
3.2 Global Fungal Otitis Externa Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fungal Otitis Externa Revenue
3.4 Global Fungal Otitis Externa Market Concentration Ratio
3.4.1 Global Fungal Otitis Externa Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fungal Otitis Externa Revenue in 2022
3.5 Fungal Otitis Externa Key Players Head office and Area Served
3.6 Key Players Fungal Otitis Externa Product Solution and Service
3.7 Date of Enter into Fungal Otitis Externa Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fungal Otitis Externa Breakdown Data by Type
4.1 Global Fungal Otitis Externa Historic Market Size by Type (2018-2023)
4.2 Global Fungal Otitis Externa Forecasted Market Size by Type (2024-2029)
5 Fungal Otitis Externa Breakdown Data by Application
5.1 Global Fungal Otitis Externa Historic Market Size by Application (2018-2023)
5.2 Global Fungal Otitis Externa Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Fungal Otitis Externa Market Size (2018-2029)
6.2 North America Fungal Otitis Externa Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Fungal Otitis Externa Market Size by Country (2018-2023)
6.4 North America Fungal Otitis Externa Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fungal Otitis Externa Market Size (2018-2029)
7.2 Europe Fungal Otitis Externa Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Fungal Otitis Externa Market Size by Country (2018-2023)
7.4 Europe Fungal Otitis Externa Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fungal Otitis Externa Market Size (2018-2029)
8.2 Asia-Pacific Fungal Otitis Externa Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Fungal Otitis Externa Market Size by Region (2018-2023)
8.4 Asia-Pacific Fungal Otitis Externa Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fungal Otitis Externa Market Size (2018-2029)
9.2 Latin America Fungal Otitis Externa Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Fungal Otitis Externa Market Size by Country (2018-2023)
9.4 Latin America Fungal Otitis Externa Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fungal Otitis Externa Market Size (2018-2029)
10.2 Middle East & Africa Fungal Otitis Externa Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Fungal Otitis Externa Market Size by Country (2018-2023)
10.4 Middle East & Africa Fungal Otitis Externa Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Fungal Otitis Externa Introduction
11.1.4 Novartis Revenue in Fungal Otitis Externa Business (2018-2023)
11.1.5 Novartis Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Fungal Otitis Externa Introduction
11.2.4 Sanofi Revenue in Fungal Otitis Externa Business (2018-2023)
11.2.5 Sanofi Recent Development
11.3 Par Pharmaceutical
11.3.1 Par Pharmaceutical Company Detail
11.3.2 Par Pharmaceutical Business Overview
11.3.3 Par Pharmaceutical Fungal Otitis Externa Introduction
11.3.4 Par Pharmaceutical Revenue in Fungal Otitis Externa Business (2018-2023)
11.3.5 Par Pharmaceutical Recent Development
11.4 Hi Tech Pharmaceuticals
11.4.1 Hi Tech Pharmaceuticals Company Detail
11.4.2 Hi Tech Pharmaceuticals Business Overview
11.4.3 Hi Tech Pharmaceuticals Fungal Otitis Externa Introduction
11.4.4 Hi Tech Pharmaceuticals Revenue in Fungal Otitis Externa Business (2018-2023)
11.4.5 Hi Tech Pharmaceuticals Recent Development
11.5 Hill Dermaceuticals
11.5.1 Hill Dermaceuticals Company Detail
11.5.2 Hill Dermaceuticals Business Overview
11.5.3 Hill Dermaceuticals Fungal Otitis Externa Introduction
11.5.4 Hill Dermaceuticals Revenue in Fungal Otitis Externa Business (2018-2023)
11.5.5 Hill Dermaceuticals Recent Development
11.6 NuLife Pharmaceuticals
11.6.1 NuLife Pharmaceuticals Company Detail
11.6.2 NuLife Pharmaceuticals Business Overview
11.6.3 NuLife Pharmaceuticals Fungal Otitis Externa Introduction
11.6.4 NuLife Pharmaceuticals Revenue in Fungal Otitis Externa Business (2018-2023)
11.6.5 NuLife Pharmaceuticals Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Fungal Otitis Externa Introduction
11.7.4 Pfizer Revenue in Fungal Otitis Externa Business (2018-2023)
11.7.5 Pfizer Recent Development
11.8 Janssen Pharmaceuticals
11.8.1 Janssen Pharmaceuticals Company Detail
11.8.2 Janssen Pharmaceuticals Business Overview
11.8.3 Janssen Pharmaceuticals Fungal Otitis Externa Introduction
11.8.4 Janssen Pharmaceuticals Revenue in Fungal Otitis Externa Business (2018-2023)
11.8.5 Janssen Pharmaceuticals Recent Development
11.9 Mylan N.V.
11.9.1 Mylan N.V. Company Detail
11.9.2 Mylan N.V. Business Overview
11.9.3 Mylan N.V. Fungal Otitis Externa Introduction
11.9.4 Mylan N.V. Revenue in Fungal Otitis Externa Business (2018-2023)
11.9.5 Mylan N.V. Recent Development
11.10 Salvat Laboratories
11.10.1 Salvat Laboratories Company Detail
11.10.2 Salvat Laboratories Business Overview
11.10.3 Salvat Laboratories Fungal Otitis Externa Introduction
11.10.4 Salvat Laboratories Revenue in Fungal Otitis Externa Business (2018-2023)
11.10.5 Salvat Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
